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Abstract: 
 
Some bacteria produce antimicrobial chemicals in their immediate environments. These 
antimicrobial agents are enzymes, polypeptides or non-protein organic compounds. In this study, 
a bacterial isolate that produces antifungal chemical(s) was isolated from an over incubated 
nutrient agar plate that was exposed to air. The bacterium is aerobic, Gram positive bacilli; 
capsule and endospore producing. It ferments glucose and sucrose but not lactose, galactose, 
mannitol and sorbitol; it is citrate, indole, methyl red and Voges Prauskauer negative. Using agar 
gel diffusion technique, the cell-free culture supernatant resulting from centrifugation of a six 
day bacterial culture showed antifungal activity against filamentous fungi but not yeasts. Heating 
the cell-free supernatant in 90 ˚C water bath and digestion with different proteases had no 
negative impact on the antifungal activity. A segment of 16S rRNA gene of the bacterial isolate 
was amplified. The nucleotide sequence of the amplicon was used to identify the bacterium as 
being very similar to Bacillus amyloliquefaciens subsp. plantarum strain FZB42. Five bacterial 
peptides were isolated and identified from cell free supernatant of the bacterial culture using a 
suite of techniques, including flash chromatography, HPLC, NMR and mass spectrometry. One 
of the five peptides has been previously reported in literature to possess antifungal activity. 
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INTRODUCTION 
 
Different types of bacteria are sources of industrial enzymes and compounds that 
have antifungal or antibacterial properties. In a study of 1200 isolates of lactic 
acid bacteria by Magnusson et al. (2003), 37 isolates showed inhibitory activity 
against different types of filamentous fungi and against the yeast Rhodotorula 
mucilaginosa. According to several studies, antifungal agents are produced by 
various species of Bacillus.  In 2014, Oyedele et al. isolated Bacillus subtilis, B. 
megaterium, B. licheniformis and B. pumilus from different food sources.  Nine 
strains of the isolated B. subtilis showed antifungal activities against a variety of 
filamentous fungi.  Some of the other studies that showed antifungal activities of 
Bacillus species include Islam et al., 2012 (Bacillus subtilis); Munimbazi and 
Bullerman, 1998 (Bacillus pumilus); Qazi et al., 2009 and Pleban et al., 1997 
(B. cereus ); Tendulkar et al., 2007, Trachuk et al., 1996 and Takayanagi et 
al., 1991 (B. licheniformis); Watanabe et al., 1990 (B. circulans). Other bacterial 
genera have also been reported to produce antifungal chemicals. As was reported 
by Fguira et al., 2005 and Rhee, Ki-Hyeong, 2003, filamentous soil bacteria 
belonging to the genus Streptomyces exhibited antifungal and antibacterial 
activities resulting from production of non-protein compounds.  Lavermicocca et 
al. (2000) isolated novel antifungal compounds from Lactobacillus plantarum 
associated with sourdough. Similarly, Chernin et al. (1995) showed that 
Enterobacter agglomerans, a soil-borne bacterium, was antagonistic to many 
plant fungi as a result of production of chitinolytic enzymes that hydrolyse fungal 
cell wall.  The antifungal agents produced by different bacterial isolates were 
characterized (Qazi et al., 2009) or isolated, purified and characterized (Fguira 
et al., 2005; Lavermicocca et al., 2000).  Most of the purified antifungal agents 
in the studies are polypeptides; some are chitinolytic enzymes while others are 
non-protein compounds, each with different properties.  Such antifungal agents 
have potential uses in agriculture where they could serve as alternatives to 
chemical fungicides that are used to prevent plant fungal diseases of agricultural 
products and plants.  Purified antifungal agents also have potential uses in cell 
culture and as food preservatives. 
In the current study, nutrient agar plates were exposed to air and incubated at 
room temperature. One of these plates was overgrown with a filamentous fungus 
except around a bacterial colony where there was inhibition of fungal growth 
(Figure 1). The aims of this study are to characterize and identify the antifungal 
bacterial isolate and also the antifungal chemical produced by the bacterial 
isolate.   
  
            
  
Figure 1 Nutrient agar plate showing a bacterial colony with antifungal activity 
indicated by a clear zone around the bacterial colony  (arrow). 
 
MATERIALS AND METHODS 
 
Initial screening of efficacy of bacterial antifungal activity    
 
The antifungal bacterium was subcultured on LB agar to obtain a pure culture.  
The efficacy of the bacterial isolate on fungal growth was done using agar 
diffusion method.  Sabouraud dextrose agar plates were prepared and separate 
plates were inoculated with a wild yeast, Candida albicans and different types of 
filamentous fungi; the plates were incubated at 25 C.  When fungal growth was 
evident on each of the plates, the bacterial isolate was then inoculated 
approximately one inch directly opposite the fungal growth; the plates were 
incubated further.  
  
Some bacteria produce antimicrobial chemicals in their immediate environments.  These antimicrobial agents are enzymes, polypeptides 
or non-protein organic compounds.  In this study, a bacterial isolate that produces antifungal chemical(s) was isolated from an over 
incubated nutrient agar plate that was exposed to air.  The bacterium is aerobic, Gram positive bacilli; capsule and endospore producing. 
It ferments glucose and sucrose but not lactose, galactose, mannitol and sorbitol; it is citrate, indole, methyl red and Voges Prauskauer 
negative.  Using agar gel diffusion technique, the cell-free culture supernatant resulting from centrifugation of a six day bacterial culture 
showed antifungal activity against filamentous fungi but not yeasts.  Heating the cell-free supernatant in 90 ˚C water bath and digestion 
with different proteases had no negative impact on the antifungal activity. A segment of 16S rRNA gene of the bacterial isolate was 
amplified.  The nucleotide sequence of the amplicon was used to identify the bacterium as being very similar to Bacillus 
amyloliquefaciens subsp. plantarum strain FZB42.  Five bacterial peptides were isolated and identified from cell free supernatant of the 
bacterial culture using a suite of techniques, including flash chromatography, HPLC, NMR and mass spectrometry. One of the five 
peptides has been previously reported in literature to possess antifungal activity. 
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Characterization of bacterial antifungal chemical 
 
The bacterial isolate was inoculated into 500 ml of LB broth and incubated at 25 
˚C in a shaker incubator.  Cell free supernatant was obtained by centrifugation of 
the culture in a Beckman Model J2-21centrifuge using JA 14 rotor.  The 
supernatant was further filtered using 0.45µM Nalgene disposable membrane 
filter ware.  The resulting cell-free supernatant was stored at 4 C.  Antifungal 
activity of the supernatant was determined using agar gel diffusion method.  
The effect of temperature on the efficacy of the antifungal agent was carried out 
by incubating the cell-free supernatant at 40 ˚C, 50 ˚C, 70 ˚C and 90 ˚C for 30 
minute.  This was followed by efficacy test against filamentous fungus using agar 
gel diffusion.    
Effect of enzyme treatment on the antifungal agent was done. The enzymes used 
were lipase, protease, proteinase K, pepsin and chymotrypsin. Culture 
supernatant was subjected to enzyme treatments for 1hr in a 37 ˚C water bath 
after which the enzyme was inactivated prior to determining the efficacy of the 
product on fungal growth.  Efficacy was determined using agar gel diffusion 
method as stated earlier. 
 
Morphological and biochemical characterization of the antifungal agent-
producing bacterial isolate 
 
Morphological characteristics of the bacterial isolate were determined using 
routine microbiological tests including Gram stain, endospore stain, capsule stain 
and motility test.  Biochemical characterization of the bacterial isolate included 
the following tests:  fermentation of different sugars, catalase production, oxidase 
test, MR-VP test, oxygen requirement test using fluid thioglycollate broth, indole 
production, citrate utilization, and production of exoenzymes for hydrolysis of 
starch, protein and lipid.  All the microbiological tests were performed as are 
described by Leboffe and Pierce (2008).  
 
Identification of bacterial isolate 
 
The bacterial isolate was identified by amplification and sequencing of segment 
of 16S rRNA gene using colony PCR and universal primers F-27 5’-
AGAGTTTGATCMTGGCTCAG-3’ and R1525  5’-
AAGGAGGTGWTCCARCC-3’.  The PCR conditions were denaturation at 94 
˚C for 5 min; 30 cycles: 94 ˚C for 30 sec, 55 ˚C for 30 sec, 72 ˚C for 1.5 min; 
final extension at 72 ˚C for 10 min.  The PCR product was cloned into TA 
cloning vector following the manufacturer’s protocol; this was followed by 
transformation.  Recombinant plasmids were prepared from selected 
transformants using Qiagen Mini Plasmid Preparation kit and were quantitated 
using NanoDrop Spectrophotometer, ND-1000.  DNA sequencing was done by 
Integrated DNA Technologies, Inc. The nucleotide sequence obtained was used 
to identify the bacterial isolate using the National Center for Biotechnology 
Information (NCBI) genomic BLAST. 
 
Purification of antifungal metabolites 
 
An extraction of the cell-free supernatant was performed by adding CHCl3-
CH3OH (4:1). The mixture was stirred for 30 min and then transferred to a 
separating funnel.  The bottom layer was drawn off and evaporated to dryness. 
The resulting organic component was further extracted with equal volume of 
CH3OH-CH3CN and hexanes; the two layers were drawn off, evaporated to 
dryness under vacuum and the dried extracts were weighed.  This was followed 
by flash chromatography of the CH3OH-CH3CN extract. The extract was 
dissolved in CHCl3 and transferred onto celite and allowed to dry. The celite was 
transferred and packed in a chromatography cartridge. At a 18 mL/min flow rate, 
a solvent gradient of 100% hexane to 100% CHCl3 to 100% CH3OH was flowed 
through the chromatography cartridge over 28 min. The sample was pooled into 
three fractions and evaporated to dryness.  Fraction 2 was dissolved in 1:1 
CH3OH–dioxane and subjected to preparative HPLC. The mobile phase was a 
gradient of CH3CN–H2O with 0.1% formic acid. The gradient flowed at 15-20% 
CH3CN over 15 min to 20% isocratic CH3CN over 20 min at a 15 mL/min flow 
rate.  The column used was an Atlantis Prep, OBD 19x250 mm column, No. 
186004026. This yielded five isolated compounds. 
 
Identification of antifungal metabolites 
 
High resolution mass spectrometry (HRMS) was performed using a QExactive 
Plus (Thermo Fisher Scientific, San Jose, CA, USA).  Resolution was 70,000, 
and MS/MS was performed with higher energy collisional dissociation (HCD) at 
52.50. Additionally, the 1H NMR (400 MHz; JEOL Ltd., Tokyo, Japan) was 
performed on the isolated compounds to confirm the structures.  
 
 
 
 
 
 
RESULTS 
 
Screening and characterization of antifungal metabolite 
 
Streak of the bacterial isolate opposite Candida albicans and filamentous fungi 
showed that the antifungal metabolite secreted into the culture medium inhibited 
only filamentous fungi. Figure 2 shows inhibition of a filamentous fungus by the 
bacterial isolate after incubation of the plate for four days.  Cell-free supernatant 
obtained from centrifugation of the antifungal bacterial isolate in LB broth also 
showed growth inhibition of filamentous fungi (Figure 3).  The results of heat 
treatment of the cell-free, culture supernatant showed that the antifungal 
metabolite is heat stable because the efficacy of the culture supernatant was not 
abrogated by the treatments (Figure 4).  Treatment of the cell-free supernatant 
with the enzymes used in the studies produced no negative effect on the efficacy 
against filamentous fungi.  
   
 
 
Figure 2. Inhibition of fungal growth after four day incubation at room 
temperature.  Inhibition is shown as a straight line, by the antifungal bacterial 
isolate “A” inoculated on one side of fungal culture. Bacterium “B” is a non 
antifungal agent producing bacterium.    
  
 
 
Figure 3. Sabouraud dextrose agar plate after two day incubation showing slight 
inhibition of filamentous fungal growth adjacent to a well that was filled with 
cell-free supernatant from the antifungal bacterial isolate culture. The inhibition 
is shown as a straight line and a decrease in the periphery of the fungal growth.  
 
 
 
Figure 4. Inhibition of fungal growth opposite wells filled with cell-free culture 
supernatants (heated at 95 ˚C for 30 min and untreated control “C”). The plate 
was incubated at room temperature for more than 8 days during which the 
supernatants in the two wells were replenished several times.  At the bottom of 
the plate is not a well but an accidental agar chip. 
                  
Morphological and biochemical characterization of antifungal bacterial 
isolate    
 
The results of morphological and biochemical tests of the bacterial isolate are 
shown in Table I. The biochemical tests were carried out after approximately 24 - 
48 hour incubation.   
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Table 1 Morphological and biochemical characteristics of the antifungal bacterial 
isolate. 
____________________________________________________________                      
              Tests       Results 
____________________________________________________________ 
        Gram Stain   Gram positive, bacilli 
        Endospores stain                                   Oval and centrally located 
        Capsule stain   Positive  
        Motility   Positive 
        Oxygen utilization                                 Aerobic 
        Catalase   Positive  
        Oxidase    Positive 
        Citrate utilization   Negative 
        Indole production  Negative 
        Methyl red            Negative 
        Voges Proskauer   Negative 
        Hydrolysis of: 
             Starch   Positive 
             Protein   Positive 
             Lipid   Negative 
             DNA                                                 Positive 
        Fermentation of: 
             Glucose   Positive 
             Sucrose   Positive 
             Lactose   Negative 
             Galactose   Negative 
             Mannitol   Negative 
             Sorbitol   Negative 
 _____________________________________________________________ 
  
Identification of bacterial isolate. 
 
A segment of 16S rRNA was amplified using universal primers F21 and R1525.   
The nucleotide sequence (1541 nucleotides) of the amplified segment of 16S 
rRNA gene of the bacterial isolate is shown in Figure 5.  The DNA sequence was 
compared with NCBI gene bank database using BLAST algorithm. The result 
showed a 99% homology of the search sequence with Bacillus amyloliquefaciens 
subsp. plantarum strain FZB42.  The nucleotide sequence was deposited in 
GenBank under accession number SUB1340497 AF-1 KU738862. 
 
 
 
Figure 5  Consensus nucleotide sequence of the amplified segment of 16S rRNA 
gene of the antifungal bacterial isolate. 
 
Purification and identification of antifungal metabolites 
 
The CHCl3-CH3OH extract from the cell-free supernatant yielded 280 mg.  Flash 
chromatography on this extract produced three fractions that weighed 0.20 mg, 
19 mg and 220 mg. While fraction three had the largest yield, analytical HPLC 
revealed that it primarily contained sugars not shown). Therefore only fraction 2 
was pursued further, which led to the isolation of compounds 1-5.  These 
compounds were tentatively identified using high resolution and tandem mass 
spectrometry (Table 2). The structures of the compounds were then confirmed 
using 1H NMR (Figures S1 {Supplement 1} through S5 {Supplement 5}). All of 
the isolated compounds were small cyclic peptides (Figure 6); the 
characterization data for each compound were in good agreement with the 
literature (Chen et al., 2009;  Nakamura et al., 2006; Stark and Hofmann,  
2005). 
 
 
 
Table 2 High resolution mass spectrometry (HRMS) and MS/MS data of the 
isolated compounds.  
_________________________________________________________________  
  Compound       [M + H]-                           MS/MS  Fragments 
                ______________________   
                Measured        Calculated 
 _________________________________________________________________                             
  1           195.1128          195.1128           195, 98, 70 
 _________________________________________________________________ 
  2           197.1284           197.1285           197, 169, 154, 141, 124, 100, 98, 72, 70 
 _________________________________________________________________  
  3           211.1440           211.1441          211, 183, 154, 138, 114, 98, 86, 70 
 _________________________________________________________________  
  4           211.1440           211.1441          211, 183, 154, 138, 114, 98, 86, 70 
 _________________________________________________________________ 
  5           245.1284           245.1285          245, 217, 172, 154, 120, 98, 70 
 ________________________________________________________________ 
 
  
 
 
Figure 6 Structures of the five isolated metabolites of Bacillus amyloliquefaciens 
subspecies plantarum strain FZB42. 
 
 
 
 
Figure S1 The structure of cis-Cyclo(L-Pro-L-Pro) (1) with the MS/MS 
fragmentation (HCD = 52.5) and 1H NMR (CDCl3, 400 MHz). 
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Figure S2 The structure of cis-Cyclo(L-Pro-L-Val) (2) with the MS/MS 
fragmentation (HCD = 52.5) and 1H NMR (CDCl3, 400 MHz). 
 
 
 
Figure S3 The structure of cis-Cyclo(L-Pro-L-Ile) (3) with the MS/MS 
fragmentation (HCD = 52.5) and 1H NMR (CDCl3, 400 MHz). 
 
 
 
 
Figure S4 The structure of cis-Cyclo(L-Pro-L-Leu) (4) with the MS/MS 
fragmentation (HCD = 52.5) and 1H NMR (CDCl3, 400 MHz). 
 
 
 
Figure S5 The structure of cis-Cyclo(L-Pro-L-Phe) (5) with the MS/MS 
fragmentation (HCD = 52.5) and 1H NMR (CDCl3, 400 MHz). 
 
DISCUSSION 
 
Microorganisms in different environments are in constant competition with each 
other for nutrients and other materials.  As a result, some bacteria produce 
bacteriocins that inhibit or kill other bacteria species while some produce 
fungicidal or fungistatic metabolites.  Similarly, some fungi produce antibacterial 
chemicals. According to Meena and Kanwar (2015), “Bacillus genus is 
considered as the factories for the production of biologically active molecules 
that are potential inhibitors of growth of phytopathogens”.  This statement by 
Meena and Kanwar is supported by the current study and by the studies 
conducted by Zhao et al. (2013), Beric et al. (2012), Chen (2012), Islam et al. 
(2012) and Nair et al. (2002). Bacteria produce antifungal metabolites that 
include different types of peptides (Meena and Kanwar, 2015; DeLucca and 
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Walsh, 2000).  In their study, Munimbazi and Bullerman (1998) reported that 
an isolate of Bacillus pumilus from a sample of dried fish was the source of an 
antifungal agent. Two different studies showed that Bacillus amyloliquefaciens 
GAI (Arguelles-Arias et al., 2009) and Bacillus amyloliquefaciens LJ02 (Li et 
al., 2015) produced secondary metabolites for the biocontrol of plant pathogen 
and for cucurbits powdery mildew, respectively.  The antifungal activity of B. 
amyloliquefaciens GAI was due to cyclic lipopeptides surfactin, iturin A and 
fengycin. The antifungal agent produced by the bacterial isolate, Bacillus 
amyloliquefaciens subsp. plantarum strain FZB42, in the current study is similar 
to that produced by B. pumilus (Munimbazi and Bullerman, 1998) in their 
inhibitory effect on filamentous fungi and not yeasts, resistance to heat treatment 
and resistance to denaturation by hydrolytic enzymes.  However, unlike the 
current study where the bacterial antifungal agent was isolated and identified, 
Munimbazi and Bullerman did not identify the antifungal agent.  In this study, 
five cyclic dipeptides were isolated from cell-free, culture supernatant of Bacillus 
amyloliquefaciens subsp. plantarum strain FZB42. The five peptides were 
identified as: cis-Cyclo(L-Pro-L-Pro) (1), cis-Cyclo(L-Pro-L-Val) (2), cis-
Cyclo(L-Pro-L-Ile) (3), cis-Cyclo(L-Pro-L-Leu) (4) and cis-Cyclo(L-Pro-L-Phe) 
(5). This report that cyclic peptide is responsible for antifungal activity the 
bacterial isolate is supported by Magnusson et al. (2003); the group reported that 
the antifungal activity of Lactobacillus coryniformis strain Si3 could be due to 
Cyclo(phe-Pro) and Cyclo(Phe-4-OH-Pro) that were identified from bacterial 
culture supernatant. While one of these five peptides, cis-Cyclo(L-Pro-L-Val) (2) 
in the current study was previously reported to have an antifungal effect, the roles 
of the other four metabolites are not exactly known.  Purified antifungal peptides 
could be a better alternative to the use of whole bacterial cells as inhibitors of 
fungal phytopathogens. The biological active, antifungal peptide could also find 
uses in the food industries as preservatives, in cell culture and in treating human 
dermatophytes.   
 
CONCLUSION 
 
It can be concluded that this study supports previous findings that members of the 
genus Bacillus produce antifungal agents. The bacterial isolate that was identified 
as Bacillus amyloliquefaciens subspecies plantarum strain FZB42 produces five 
peptide metabolites; at least one of these peptide metabolites (cis-Cyclo(L-Pro-L-
Val) is a known and unique antifungal agent that is resistant to high temperature 
and hydrolytic enzymes. Future work is to synthesize: cis-Cyclo(L-Pro-L-Pro) 
(1), cis-Cyclo(L-Pro-L-Ile) (3), cis-Cyclo(L-Pro-L-Leu) (4) and cis-Cyclo(L-Pro-
L-Phe) (5) and study their efficacy against fungi and bacteria.   
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